Showing results (1931-1940 of 3,160) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 8, 2012
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral siteMichelle W Ma, Meng Qian, Daniel J Lackaye, et al.
Neuro-Oncology|November 17, 2011
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microgliaValerie L Jacobs, Russell P Landry, Yingna Liu, et al.
Neuro-Oncology|February 11, 2012
Phase I study of terameprocol in patients with recurrent high-grade gliomaStuart A Grossman, Xiaobu Ye, David Peereboom, et al.
Neuro-Oncology|January 20, 2012
The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cellsLatika Kohli, Niroop Kaza, Nicholas J Lavalley, et al.
Neuro-Oncology|December 14, 2011
Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)Takashi Sasayama, Satoshi Nakamizo, Masamitsu Nishihara, et al.
Neuro-Oncology|February 3, 2012
Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomographyKathy Hasenbach, Stefan Wiehr, Caroline Herrmann, et al.
Neuro-Oncology|February 10, 2012
Consensus on the role of human cytomegalovirus in glioblastomaKristine Dziurzynski, Susan M Chang, Amy B Heimberger, et al.
Neuro-Oncology|April 17, 2012
Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivoHarpreet Kaur, Susan M Burden-Gulley, Polly J Phillips-Mason, et al.
Neuro-Oncology|August 19, 2011
Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic targetStuart J Smith, Angela Long, Jennifer H Barrow, et al.
Neuro-Oncology|September 6, 2011
Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging studyElke Hattingen, Alina Jurcoane, Oliver Bähr, et al.
Pageof 316